The purposes of this study were to determine whether planar 123 I-MIBG imaging-derived parameters such as H/M or WR are associated with quantitative parameters measured by 11 C-HED PET, and to directly compare image quality, defect size, and location between 123 I-MIBG SPECT and 11 C-HED PET.
Methods

Study Population
This was a retrospective analysis of observational study to characterize HF using imaging biomarkers. Although the imaging protocol included 11 C-acetate PET to assess oxidative metabolism, this part was not used in this study. 123 I-MIBG imaging was performed when it is clinically indicated by referring physician. We consecutively screened 38 patients who had been referred to The Medical and Pharmacological Research Center Foundation as potential candidates of the study using the following criteria: (1) angiographically proven CHD or nonischemic symptomatic HF, because both disease conditions are known to cause abnormalities in cardiac sympathetic innervation, 7, 15 (2) regional or global (left ventricular ejection fraction [LVEF] of Ͻ50%) left ventricular (LV) dysfunction documented by echocardiography or ECG-gated myocardial perfusion SPECT at entry, and (3) both 123 I-MIBG imaging and 11 C-HED PET having been performed under stable general condition within 1 month after the entry. The first criterion was met in all 38 patients; the second criterion was met in 31 patients. Of these, 21 patients met the third criterion and thus were included in the study. Patients were excluded if they (1) had decompensated HF, (2) had acute coronary events (Ͻ10 days) such as myocardial infarction or unstable angina before the imaging study, (3) had any cardiac event or clinical instability requiring changes in medical treatment between the 2 imaging visits, or (4) were premenopausal women. All cardiac medications such as ␤-blockers were continued during the study period for safety reasons. All patients underwent 123 I-MIBG imaging and 11 C-HED PET within a mean of 5.7 days (1 to 16 days). The study protocol was approved by the institutional ethical committee and written informed consent was obtained from all the participants at the time of screening. 123 
I-MIBG Imaging
Anterior planar imaging for 5 minutes was performed 15 minutes and 3 hours after intravenous injection of 111 MBq of 123 I-MIBG using a triple-head camera system (Prism 3000, Picker, Cleveland, Ohio) equipped with low-energy parallel-hole collimators. Images were acquired for 5 minutes using 512ϫ512 matrices. After completion of planar imaging, SPECT was acquired for 15 minutes in 64ϫ64 matrices over 360°with an acquisition time of 30 seconds per projection in 4°increments. An energy window centered on the 159Ϯ15.9 keV. The image data were reconstructed by use of a standard filtered back-projection with a Butterworth filter (cutoff frequency, 0.24; order 8). Neither attenuation nor scatter correction was performed.
The H/M was measured for both early (15-minute) and late (3-hour) images by placing the regions of interest on the entire LV myocardium and upper mediastinum. Additionally, background and decay corrected WR from the early to delayed images was calculated. 6
Positron Emission Tomography
PET imaging was performed using a full-ring PET scanner (Advance, GE Healthcare). After positioning the subject in a supine position in the gantry, transmission scan for 15 minutes was performed using 68 Ge/ 68 Ga pin sources for attenuation correction. After completion of transmission scan, 600 MBq of 11 C-HED was intravenously injected, and a dynamic imaging sequence (14 frames, 6ϫ30, 2ϫ60, 2ϫ150, 2ϫ300, and 2ϫ600 seconds) was acquired. Additionally, venous blood samples were drawn to measure plasma norepinephrine (NE) and brain nautriuretic peptide (BNP) as the neurohormonal markers of HF severity.
Attenuation-corrected transaxial images were reconstructed using ordered subset expectation maximization algorithm. The image data matrix was 128ϫ128 with pixel sizes of 2.73 mm and a slice thickness of 4.25 mm. Both attenuation and scatter corrections were used during image reconstruction.
Processing of PET Data
A volumetric sampling procedure was used to create polar maps of activity distribution throughout the entire LV myocardium. From the dynamic PET images, global myocardial 11 C-HED retention fraction was calculated as the LV myocardial activity at the last frame (30 to 40 minutes) divided by the integral of the arterial blood activity curve, which was derived from a small circular region of interest in the left ventricular cavity. Additionally, 11 C-HED WR was obtained as the difference in activity between the early (10-to 15-minute) and the late (30-to 40-minute) images divided by the early image. 16
Comparison of 123 I-MIBG SPECT and 11 C-HED PET
For tomographic data, image quality was assessed by 2 readers. Each SPECT or PET image data set was assigned good, fair, or poor (suboptimal). The disagreements in image quality assignment was resolved by consensus. The patients with poor image quality in at least 1 of the 3 image data sets (ie, early and late 123 I-MIBG SPECT, and 11 C-HED PET) were excluded from further analysis because reliable defect size quantification would not be possible in such patients.
Comparison of defect size and location between 123 I-MIBG SPECT and 11 C-HED PET was performed using a semiquantitative polar map approach, which was developed and validated at the Technical University of Munich. 17 The SPECT and PET images were normalized to the mean of 6 connected sectors showing the highest overall uptake in the LV myocardium. A pixel in the patient's map was considered abnormal if its count activity was Ͻ60% of the maximum. 18 The defect size was measured for the apical, anterior, septal, lateral, and inferior regions and for the whole LV, and was expressed as the percentage of LV myocardium (%LV).
Intraobserver and Interobserver Agreements
To test intraobserver agreement of defect size measurements, a single reader analyzed both 123 I-MIBG SPECT and 11 C-HED PET twice in every patient. To reduce recall bias, the second analysis was performed at least 1 month after the first analysis. Additionally, the data were analyzed independently by another reader to test interobserver agreement.
Echocardiography
Echocardiography was performed in all patients on the same day of PET imaging using Vivid 7 (GE Healthcare) with a 4-MHz transducer. LVEF was measured using the Simpson biplane method.
Statistical Analysis
Data are expressed as meanϮ1SD. A paired t test was used for comparison of hemodynamic variables between the 2 imaging visits. Correlations of variables were analyzed by linear regression. The defect size between 123 I-MIBG SPECT and 11 C-HED PET was compared using repeated-measures ANOVA, followed by the Dunnett multiple comparison test. For correlation analysis of imaging versus neurohormonal parameters, the logarithmical transformation of BNP was performed to normalize the distribution of its plasma concentration because BNP is known to be rarely normally distributed. 19, 20 Intraobserver and interobserver agreements were assessed by intraclass correlation coefficient and Bland-Altman plots. Analysis was performed using SPSS 18, JMP 8, or GraphPad Prism 5, where appropriate.
Results
Patient Characteristics
Patient characteristics are summarized in Table 1 . There were 15 men and 6 women with a mean age of 66Ϯ8 years. In this study, none of the 21 patients met the exclusion criteria and had to be excluded from the study because they were in stable 
C-HED PET
As illustrated in Figure 1 , both the early and late 123 I-MIBG H/M were significantly correlated with 11 C-HED retention.
Additionally, there was a significant correlation between 123 I-MIBG WR and 11 C-HED WR (rϭ0.57, PϽ0.01).
The relationships between 123 I-MIBG or 11 C-HED parameters versus functional or neurohormonal measures of HF severity are summarized in Table 2 . LVEF was significantly correlated with most of the image-derived parameters except for early 123 I-MIBG H/M. Plasma NE showed a close correlation with 11 C-HED WR (0.78) and a moderate correlation with 123 I-MIBG WR (0.44) but did not with 123 I-MIBG H/M or 11 C-HED retention. Additionally, 123 I-MIBG H/M or 11 C-HED retention was negatively correlated with logarithm of plasma BNP, whereas 123 I-MIBG WR or 11 C-HED WR was positively correlated with it.
123
I-MIBG SPECT and 11 C-HED PET
Image Quality Assessment of Tomographic Data
By visual inspection, the quality of 11 C-HED images was judged as good in all 21 patients. For the early 123 I-MIBG SPECT, the image quality was fair in all 21 patients. For the late 123 I-MIBG SPECT, the quality was fair in 18 patients and was poor in 3 patients. These 3 patients with poor-quality late 123 I-MIBG images were considered to be suboptimal for defect size quantification and were therefore excluded from the further analysis, whereas 11 C-HED defect was measurable in all patients. The mean late H/M in this subgroup was 1.57Ϯ0.19, as compared with 1.90Ϯ0.29 (Pϭ0.08) in the remaining patients with acceptable image quality. An example of poor 123 I-MIBG image quality is presented in Figure 2 .
Intraobserver and Interobserver Reproducibility
Intraobserver and interobserver agreements were good for both PET and SPECT, with intraclass correlation coefficients of 0.98 to 0.99 for intraobserver and 0.95 to 0.99 for interobserver agreement. Bland-Altman plots demonstrated no evidence of systemic bias for both 123 I-MIBG SPECT and 11 C-HED PET (Figure 3 ), although the limits of 2SDs of the difference of 123 I-MIBG SPECT tended to be wider as compared with those of 11 C-HED PET.
Comparison of Defect Size and Location Between 123 I-MIBG SPECT and 11 C-HED PET
The relationships of defect size between 123 I-MIBG SPECT and 11 C-HED PET are shown in Figure 4 . The defect size measured by either early or late 123 I-MIBG SPECT was closely correlated with that measured by 11 C-HED PET. Comparison of defect size between 123 I-MIBG SPECT and 11 C-HED PET are summarized in Table 3 . There was no significant difference in total defect size between the early 123 I-MIBG SPECT and 11 C-HED PET. The late 123 I-MIBG SPECT, on the other hand, showed a larger defect as compared with 11 C-HED PET. When the defect sizes were further analyzed according to their location, the inferior and septal regions showed a larger late 123 I-MIBG defect than 11 C-HED. Conversely, the apex and anterior region showed a slightly smaller 123 I-MIBG defect than 11 C-HED. Figure 5 illustrates a representative case example with a more extensive inferior defect with 123 I-MIBG SPECT than with 11 C-HED PET.
Discussion
To the best of our knowledge, this is the first study that compared 123 I-MIBG imaging and 11 C-HED PET in the same individual patients. The major findings of this study were that (1) 123 I-MIBG H/M were significantly correlated with quan- titative measure of sympathetic innervation (ie, 11 C-HED retention) by PET, (2) cardiac 11 C-HED WR was significantly correlated with 123 I-MIBG WR and plasma NE level, (3) 11 C-HED PET consistently showed better image quality than 123 I-MIBG SPECT, and (4) late 123 I-MIBG SPECT overestimated the defect area particularly in the inferior and septal regions as compared with 11 C-HED PET. 123 I-MIBG and 11 C-HED are currently the most established single-photon and positron-emitting tracers for assessing cardiac presynaptic sympathetic neuronal integrity. 7, 15 Both tracers are analogs of NE, not metabolized, and thus marks the location of functioning nerve terminals. 11, 21 Our prior experimental study using rabbit hearts has shown that both tracers are highly specific for sympathetic neurons. 16 From a technical viewpoint, however, there are many differences between planar imaging and PET. The former only gives semiquantitative parameters such as H/M, whereas the later provides truly quantitative measures of neuronal density. 22 Despite this, 123 I-MIBG H/M, particularly late H/M, were well correlated with 11 C-HED retention, supporting the concept that the simple semiquantitative H/M gives a reliable estimate of cardiac sympathetic innervation.
123
I-MIBG and 11 C-HED as Tracers for Assessing Cardiac Sympathetic Innervation
In the present study, we measured plasma NE and BNP as neurohormonal makers of HF severity because these markers reflect different pathophysiologic aspects of HF. BNP is released from the myocardium and its plasma level reflects myocardial wall stress, 19 whereas plasma NE is a marker of systemic sympathetic nerve activation. 23 Although plasma NE is elevated only at a later stage of HF, 24 both markers are known to provide important prognostic information in HF patients. 19, 23 It should also be noted that unlike the imaging parameters tested in this study such as 123 I-MIBG H/M and 11 C-HED retention, plasma NE is not specific for cardiac sympathetic function. When the imaging parameters were compared with functional or neurohormonal parameters, 11 C-HED retention showed a similar correlation pattern (ie, significant correlations with LVEF and plasma BNP, but not with NE) to late 123 I-MIBG H/M, suggesting that 11 C-HED retention and late 123 I-MIBG H/M may reflect similar physiological aspects of HF. It is also notable that 11 C-HED WR was significantly correlated with plasma NE. To date, only little attention has been given to 11 C-HED WR in literature. Besides the short physical half-life of 11 C, a possible reason for this is that 11 C-HED binding to storage vesicles is considered to be relatively low as compared with that of NE. 15 However, our prior experimental study in rabbit hearts has shown that reserpine inhibitable fraction of 11 C-HED is greater than that of 123 I-MIBG, 16 suggesting that the former is more specific for intravesicular uptake than the later. In this regard, it is conceivable that 11 C-HED WR may reflect cardiac sympathetic nerve activity at least to some degree, as does 123 I-MIBG WR, although the clinical value of 11 C-HED WR remains to be elucidated by further studies. This is also supported by the significant correlation between 11 C-HED WR and 123 I-MIBG WR observed in this study.
Tomographic Imaging
There is a general agreement that the sympathetic nervous system plays an important role in the genesis of ventricular arrhythmias and an increased risk of sudden death. 25 Recent studies have shown that the regional variation of presynaptic sympathetic function as assessed by SPECT 10 or PET 26 may be linked to some forms of lethal ventricular arrhythmias. However, image quality is a critical issue for reliable measurement of such regional abnormalities on tomographic data. Our results demonstrated that 11 C-HED PET consistently showed better image quality than 123 I-MIBG SPECT. More importantly, a small but not negligible number of patients (14%) showed poor-quality late 123 I-MIBG images, where measurement of regional abnormalities was not possible in a reliable manner. The quality of 11 C-HED PET images was still good in all such patients, indicating that 11 C-HED PET is more suitable for assessment of regional abnormalities than 123 I-MIBG SPECT. In other words, regional analysis with 123 I-MIBG SPECT may be difficult when its image quality is suboptimal. It is also important to note that image quality may affect reproducibility of measurements, which is supported by our data showing a trend toward lower variability with 11 C-HED PET than with 123 I-MIBG SPECT. The better image quality of PET than SPECT is not surprising considering the technical advantages of PET over SPECT. Additionally, the lower injected dose of 123 I-MIBG (111 MBq) relative to that of 11 C-HED (600 MBq) may have contributed to the lower image quality. However, this reflects the standard 123 I-MIBG imaging protocol practiced in Japan, 6, 9, 27, 28 where 111 MBq is the maximum dose limit for this tracer. Furthermore, the intense adjacent liver uptake relative to the myocardium, as illustrated in Figure 2 , is not likely to be improved by increasing the 123 I-MIBG dose.
Despite the image quality differences described above, the defect size measured by 123 I-MIBG SPECT was closely correlated with that measured by 11 C-HED PET, indicating that 123 I-MIBG SPECT provides measures of regional sympathetic innervation if the image quality is acceptable. However, the late 123 I-MIBG SPECT significantly overestimated defect area as compared with 11 C-HED PET, particularly in the inferior and septal regions. In addition to possible differences in tracer kinetics between 123 I-MIBG and 11 C-HED, 16 attenuation artifacts may certainly have contributed to the results. Inferior and septal regions are known to be susceptible to attenuation artifacts, which is particularly true in patients with dilated LV such as those encountered in HF. 29 Furthermore, intense liver activity may have further lessened the inferior myocardial activity during image reconstruction. 30
Limitations
There are limitations of the study to be described. First, the most significant limitation of the study is the lack of attenuation correction for 123 I-MIBG SPECT, which would have had a significant impact on SPECT image quality and would make a proper comparison of the 2 tracers difficult. Additionally, relatively low spatial resolution of current SPECT system limits the clear delineation of myocardium from the liver, which may be further enhanced after correction. Perhaps for this reason, attenuation correction for cardiac 123 I-MIBG SPECT has not yet been used in any of published data. Nevertheless, we believe that further instrumental work should be directed toward implementation of attenuation correction together with improved spatial resolution and counting sensitivity. This would improve SPECT image quality and enable more accurate 123 I-MIBG SPECT measurements, which may be possible using newer generation cameras. 31 Second, both PET and SPECT images were normalized to the maximum of LV myocardium and a simple 60% threshold was used to define defect area, which abolishes any difference in global tracer retention because the maximum is always set to 100%. This is unavoidable with 123 I-MIBG due to the nonquantitative nature of SPECT. A true regional defect versus normal will thus be underestimated in case of overall downregulation of innervation that includes remote myocardium. Thus, if PET is used and regional absolute retention is compared with normal, defect size will be more accurately assessed. We could not cover this issue in the present study because we did not include normal data bases for comparison.
Third, we relied on 11 C-HED retention/washout as PET measures of presynaptic sympathetic function because they are simple and stable. More sophisticated compartment kinetic models have also been used for 11 C-HED. 32, 33 Although they are technically more demanding, the model based quantitative parameters such as volume of distribution 33 (Vd) may be more specific to presynaptic uptake-1 function than is 11 C-HED retention. The comparative clinical significance of these 11 C-HED parameters remains to be investigated in further studies. Furthermore, we assessed only presynaptic neuronal function in the current study. The combination of presynaptic and postsynaptic functions using PET has been reported in patients with arrhythmogenic heart diseases 33, 34 and HF, 35 which would provide more comprehensive understanding of underlying pathophysiology.
Fourth, plasma BNP, NE, and LVEF were measured on the day of 11 C-HED PET, and therefore it is possible that these measurements would have been more favorably correlated with 11 C-HED results than with 123 I-MIBG. Although the both imaging procedures were performed under stable clini- cal conditions with relatively short intervals (mean 5.7 days), this possibility cannot be ruled out.
Fifth, the study patients were heterogeneous in underlying etiology, including ischemic and nonischemic cardiac diseases. However, it has been shown that sympathetic neuronal imaging reflects the disease severity independent of underlying cause, 1 which was true in the current study as demonstrated by the relationship between imaging parameters and functional or neurohormonal markers of HF. Finally, outcome data were not obtained in this study and therefore comparative prognostic value of 123 I-MIBG imaging and 11 C-HED PET is unknown.
Conclusion
Semiquantitative 123 I-MIBG H/M gives a reliable estimate of cardiac sympathetic innervation as measured by 11 C-HED PET. Additionally, 11 C-HED WR may serve as an index of cardiac sympathetic neuronal activity, as does 123 I-MIBG WR, although this must be validated in further studies. As for tomographic imaging, although there is a close correlation in measured defect size between SPECT and PET, the late 123 I-MIBG SPECT overestimates defect size particularly in the inferior and septal regions. More importantly, 11 C-HED PET consistently yields better quality images and appears to be more suitable for assessing regional abnormalities than 123 I-MIBG SPECT. In other words, regional analysis with 123 I-MIBG SPECT may be difficult when its image quality is suboptimal.
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